|
|
 Previous Article | Table of Contents | Next Article 
RAPID COMMUNICATION
Retroviral-Mediated Transfer of the Green Fluorescent Protein Gene Into Murine Hematopoietic Cells Facilitates Scoring and Selection of Transduced Progenitors In Vitro and Identification of Genetically Modified Cells In Vivo
Derek A. Persons,
James A. Allay,
Esther R. Allay,
Richard J. Smeyne,
Richard A. Ashmun,
Brian P. Sorrentino, and
Arthur W. Nienhuis
From the Division of Experimental Hematology, the Department of Hematology/Oncology, the Department of Developmental Neurobiology, and the Department of Experimental Oncology, St Jude Children's Research Hospital, Memphis, TN.
We have investigated the utility of the green fluorescent protein (GFP) to serve as a marker to assess retroviral gene transfer into hematopoietic cells and as a tool to identify and enrich for cells expressing high levels of the vector-encoded transcript. GFP, by virtue of a naturally occurring chromophore encoded in its primary sequence, displays autonomous fluorescence, thus eliminating the need for antibody or cytochemical staining to detect its expression. A bicistronic murine stem cell virus (MSCV)-based retroviral vector was constructed containing the GFP cDNA and a mutant, human dihydrofolate reductase gene. High-titer, ecotropic retroviral producer cells free of replication competent virus were generated and used to transduce murine bone marrow cells by cocultivation. Within 24 hours after completion of the transduction procedure, a high proportion (40% to 70%) of the marrow cells were intensely fluorescent compared to mock-transduced cells or cells transduced with a control retrovirus. Erythroid and myeloid hematopoietic colonies derived from GFP-transduced marrow were easily scored for retroviral gene transfer by direct in situ fluorescence microscopy. Clonogenic progenitors expressing increased levels of antifolate drug resistance could be enriched from the GFP-transduced marrow population by fluorescence activated cell sorting of cells expressing high levels of GFP. In vivo, splenic hematopoietic colonies and peripheral blood cells from animals transplanted with GFP-transduced marrow displayed intense fluorescence. These results show that GFP is an excellent marker for scoring and tracking gene-modified hematopoietic cells and for allowing rapid selection and enrichment of transduced cells expressing high levels of the transgene.
Blood, Vol. 90 No. 5 (September 1), 1997:
pp. 1777-1786
© 1997 by The American Society of Hematology.
 CiteULike  Connotea  Del.icio.us  Digg  Reddit  Technorati What's this?
This article has been cited by other articles:
|
|
|
|
 
K. Rubtsova, J. P. Scott-Browne, F. Crawford, S. Dai, P. Marrack, and J. W. Kappler
Many different V{beta} CDR3s can reveal the inherent MHC reactivity of germline-encoded TCR V regions
PNAS,
May 12, 2009;
106(19):
7951 - 7956.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
S. Mumprecht, C. Claus, C. Schurch, V. Pavelic, M. S. Matter, and A. F. Ochsenbein
Defective homing and impaired induction of cytotoxic T cells by BCR/ABL-expressing dendritic cells
Blood,
May 7, 2009;
113(19):
4681 - 4689.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
R. Alli, P. Nguyen, and T. L. Geiger
Retrogenic Modeling of Experimental Allergic Encephalomyelitis Associates T Cell Frequency but Not TCR Functional Affinity with Pathogenicity
J. Immunol.,
July 1, 2008;
181(1):
136 - 145.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. Dominici, R. Marino, V. Rasini, C. Spano, P. Paolucci, P. Conte, T. J. Hofmann, and E. M. Horwitz
Donor cell-derived osteopoiesis originates from a self-renewing stem cell with a limited regenerative contribution after transplantation
Blood,
April 15, 2008;
111(8):
4386 - 4391.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
Z. Z. Lieu, J. G. Lock, L. A. Hammond, N. L. La Gruta, J. L. Stow, and P. A. Gleeson
A trans-Golgi network golgin is required for the regulated secretion of TNF in activated macrophages in vivo
PNAS,
March 4, 2008;
105(9):
3351 - 3356.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
I. Moisini, P. Nguyen, L. Fugger, and T. L. Geiger
Redirecting Therapeutic T Cells against Myelin-Specific T Lymphocytes Using a Humanized Myelin Basic Protein-HLA-DR2-{zeta} Chimeric Receptor
J. Immunol.,
March 1, 2008;
180(5):
3601 - 3611.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. L. Gori, K. Podetz-Pedersen, D. Swanson, A. D. Karlen, R. Gunther, N. V. Somia, and R. S. McIvor
Protection of Mice from Methotrexate Toxicity by ex Vivo Transduction Using Lentivirus Vectors Expressing Drug-Resistant Dihydrofolate Reductase
J. Pharmacol. Exp. Ther.,
September 1, 2007;
322(3):
989 - 997.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. K. Dobbs, T. Yang, D. Farmer, L. Kager, O. Parolini, and M. E. Conley
Cutting Edge: A Hypomorphic Mutation in Igbeta (CD79b) in a Patient with Immunodeficiency and a Leaky Defect in B Cell Development
J. Immunol.,
August 15, 2007;
179(4):
2055 - 2059.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
K. Schuster, L. Fan, and L. C. Harris
MDM2 Splice Variants Predominantly Localize to the Nucleoplasm Mediated by a COOH-Terminal Nuclear Localization Signal
Mol. Cancer Res.,
April 1, 2007;
5(4):
403 - 412.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
K. C. El Kasmi, J. Holst, M. Coffre, L. Mielke, A. de Pauw, N. Lhocine, A. M. Smith, R. Rutschman, D. Kaushal, Y. Shen, et al.
General Nature of the STAT3-Activated Anti-Inflammatory Response
J. Immunol.,
December 1, 2006;
177(11):
7880 - 7888.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. Priller, M. Prinz, M. Heikenwalder, N. Zeller, P. Schwarz, F. L. Heppner, and A. Aguzzi
Early and Rapid Engraftment of Bone Marrow-Derived Microglia in Scrapie.
J. Neurosci.,
November 8, 2006;
26(45):
11753 - 11762.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
R. Seggewiss, S. Pittaluga, R. L. Adler, F. J. Guenaga, C. Ferguson, I. H. Pilz, B. Ryu, B. P. Sorrentino, W. S. Young III, R. E. Donahue, et al.
Acute myeloid leukemia is associated with retroviral gene transfer to hematopoietic progenitor cells in a rhesus macaque
Blood,
May 15, 2006;
107(10):
3865 - 3867.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
C. Carella, M. Potter, J. Bonten, J. E. Rehg, G. Neale, and G. C. Grosveld
The ETS factor TEL2 is a hematopoietic oncoprotein
Blood,
February 1, 2006;
107(3):
1124 - 1132.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. L. Szymczak, C. J. Workman, D. Gil, S. Dilioglou, K. M. Vignali, E. Palmer, and D. A. A. Vignali
The CD3{epsilon} Proline-Rich Sequence, and Its Interaction with Nck, Is Not Required for T Cell Development and Function
J. Immunol.,
July 1, 2005;
175(1):
270 - 275.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. Cardone, A. Kandilci, C. Carella, J. A. Nilsson, J. A. Brennan, S. Sirma, U. Ozbek, K. Boyd, J. L. Cleveland, and G. C. Grosveld
The Novel ETS Factor TEL2 Cooperates with Myc in B Lymphomagenesis
Mol. Cell. Biol.,
March 15, 2005;
25(6):
2395 - 2405.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
C. J. Workman and D. A. A. Vignali
Negative Regulation of T Cell Homeostasis by Lymphocyte Activation Gene-3 (CD223)
J. Immunol.,
January 15, 2005;
174(2):
688 - 695.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. Kawahara, Y. Ogo, H. Ueda, and T. Nagamune
Improved growth response of antibody/receptor chimera attained by the engineering of transmembrane domain
Protein Eng. Des. Sel.,
October 1, 2004;
17(10):
715 - 719.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
H. Kawagoe, M. Potter, J. Ellis, and G. C. Grosveld
TEL2, an ETS Factor Expressed in Human Leukemia, Regulates Monocytic Differentiation of U937 Cells and Blocks the Inhibitory Effect of TEL1 on Ras-Induced Cellular Transformation
Cancer Res.,
September 1, 2004;
64(17):
6091 - 6100.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
P. Y. Arnold, A. R. Burton, and D. A. A. Vignali
Diabetes Incidence Is Unaltered in Glutamate Decarboxylase 65-Specific TCR Retrogenic Nonobese Diabetic Mice: Generation by Retroviral-Mediated Stem Cell Gene Transfer
J. Immunol.,
September 1, 2004;
173(5):
3103 - 3111.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
Y. Sasaki, C. T. Jensen, S. Karlsson, and S. E. W. Jacobsen
Enforced expression of cyclin D2 enhances the proliferative potential of myeloid progenitors, accelerates in vivo myeloid reconstitution, and promotes rescue of mice from lethal myeloablation
Blood,
August 15, 2004;
104(4):
986 - 992.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. Dominici, C. Pritchard, J. E. Garlits, T. J. Hofmann, D. A. Persons, and E. M. Horwitz
Hematopoietic cells and osteoblasts are derived from a common marrow progenitor after bone marrow transplantation
PNAS,
August 10, 2004;
101(32):
11761 - 11766.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. Chen, I. R. Williams, J. L. Kutok, N. Duclos, E. Anastasiadou, S. C. Masters, H. Fu, and D. G. Gilliland
Positive and negative regulatory roles of the WW-like domain in TEL-PDGF{beta}R transformation
Blood,
July 15, 2004;
104(2):
535 - 542.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
D. A. Persons, J. A. Allay, A. Bonifacino, T. Lu, B. Agricola, M. E. Metzger, R. E. Donahue, C. E. Dunbar, and B. P. Sorrentino
Transient in vivo selection of transduced peripheral blood cells using antifolate drug selection in rhesus macaques that received transplants with hematopoietic stem cells expressing dihydrofolate reductase vectors
Blood,
February 1, 2004;
103(3):
796 - 803.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
P. Nguyen, I. Moisini, and T. L. Geiger
Identification of a murine CD28 dileucine motif that suppresses single-chain chimeric T-cell receptor expression and function
Blood,
December 15, 2003;
102(13):
4320 - 4325.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
E. L. Kreklau, K. E. Pollok, B. J. Bailey, N. Liu, J. R. Hartwell, D. A. Williams, and L. C. Erickson
Hematopoietic expression of O6-methylguanine DNA methyltransferase-P140K allows intensive treatment of human glioma xenografts with combination O6-benzylguanine and 1,3-bis-(2-chloroethyl)-1-nitrosourea
Mol. Cancer Ther.,
December 1, 2003;
2(12):
1321 - 1329.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
Z. Xu, S. Huang, L.-S. Chang, A. D. Agulnick, and S. J. Brandt
Identification of a TAL1 Target Gene Reveals a Positive Role for the LIM Domain-Binding Protein Ldb1 in Erythroid Gene Expression and Differentiation
Mol. Cell. Biol.,
November 1, 2003;
23(21):
7585 - 7599.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
T. S. Strom, S. J. Turner, S. Andreansky, H. Liu, P. C. Doherty, D. K. Srivastava, J. M. Cunningham, and A. W. Nienhuis
Defects in T-cell-mediated immunity to influenza virus in murine Wiskott-Aldrich syndrome are corrected by oncoretroviral vector-mediated gene transfer into repopulating hematopoietic cells
Blood,
November 1, 2003;
102(9):
3108 - 3116.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
P. Kurre, J. Morris, B. Thomasson, D. B. Kohn, and H.-P. Kiem
Scaffold attachment region-containing retrovirus vectors improve long-term proviral expression after transplantation of GFP-modified CD34+ baboon repopulating cells
Blood,
November 1, 2003;
102(9):
3117 - 3119.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. Tajima, T. Tanaka, T. Ebata, K. Takeda, A. Kawasaki, J. M. Kelly, P. K. Darcy, R. E. Vance, D. H. Raulet, K. Kinoshita, et al.
Blastocyst MHC, a Putative Murine Homologue of HLA-G, Protects TAP-Deficient Tumor Cells from Natural Killer Cell-Mediated Rejection In Vivo
J. Immunol.,
August 15, 2003;
171(4):
1715 - 1721.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. Kawahara, H. Ueda, S. Morita, K. Tsumoto, I. Kumagai, and T. Nagamune
Bypassing antibiotic selection: positive screening of genetically modified cells with an antigen-dependent proliferation switch
Nucleic Acids Res.,
April 1, 2003;
31(7):
e32 - e32.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
D. A. Persons, P. W. Hargrove, E. R. Allay, H. Hanawa, and A. W. Nienhuis
The degree of phenotypic correction of murine beta -thalassemia intermedia following lentiviral-mediated transfer of a human gamma -globin gene is influenced by chromosomal position effects and vector copy number
Blood,
March 15, 2003;
101(6):
2175 - 2183.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M.-L. Kuo, E. J. Duncavage, R. Mathew, W. den Besten, D. Pei, D. Naeve, T. Yamamoto, C. Cheng, C. J. Sherr, and M. F. Roussel
Arf Induces p53-dependent and -independent Antiproliferative Genes
Cancer Res.,
March 1, 2003;
63(5):
1046 - 1053.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. C. Desmond, J. C. Mountford, M. T. Drayson, E. A. Walker, M. Hewison, J. P. Ride, Q. T. Luong, R. E. Hayden, E. F. Vanin, and C. M. Bunce
The Aldo-Keto Reductase AKR1C3 Is a Novel Suppressor of Cell Differentiation That Provides a Plausible Target for the Non-Cyclooxygenase-dependent Antineoplastic Actions of Nonsteroidal Anti-Inflammatory Drugs
Cancer Res.,
January 15, 2003;
63(2):
505 - 512.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. E. Grove, C. Lutzko, J. Priller, O. Henegariu, N. D. Theise, D. B. Kohn, and D. S. Krause
Marrow-Derived Cells as Vehicles for Delivery of Gene Therapy to Pulmonary Epithelium
Am. J. Respir. Cell Mol. Biol.,
December 1, 2002;
27(6):
645 - 651.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
C. J. Workman, K. J. Dugger, and D. A. A. Vignali
Cutting Edge: Molecular Analysis of the Negative Regulatory Function of Lymphocyte Activation Gene-3
J. Immunol.,
November 15, 2002;
169(10):
5392 - 5395.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
S. M. Knoetig, T. A. Torrey, Z. Naghashfar, T. McCarty, and H. C. Morse III
CD19 Signaling Pathways Play a Major Role for Murine AIDS Induction and Progression
J. Immunol.,
November 15, 2002;
169(10):
5607 - 5614.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. Otsu, M. Steinberg, C. Ferrand, P. Merida, C. Rebouissou, P. Tiberghien, N. Taylor, F. Candotti, and N. Noraz
Reconstitution of lymphoid development and function in ZAP-70-deficient mice following gene transfer into bone marrow cells
Blood,
July 30, 2002;
100(4):
1248 - 1256.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
L. M. Kelly, J. L. Kutok, I. R. Williams, C. L. Boulton, S. M. Amaral, D. P. Curley, T. J. Ley, and D. G. Gilliland
PML/RARalpha and FLT3-ITD induce an APL-like disease in a mouse model
PNAS,
June 11, 2002;
99(12):
8283 - 8288.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
T. Leimig, L. Mann, M. d. P. Martin, E. Bonten, D. Persons, J. Knowles, J. A. Allay, J. Cunningham, A. W. Nienhuis, R. Smeyne, et al.
Functional amelioration of murine galactosialidosis by genetically modified bone marrow hematopoietic progenitor cells
Blood,
May 1, 2002;
99(9):
3169 - 3178.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. Dang, M.-L. Kuo, C. M. Eischen, L. Stepanova, C. J. Sherr, and M. F. Roussel
The RING Domain of Mdm2 Can Inhibit Cell Proliferation
Cancer Res.,
February 1, 2002;
62(4):
1222 - 1230.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
L. M. Kelly, Q. Liu, J. L. Kutok, I. R. Williams, C. L. Boulton, and D. G. Gilliland
FLT3 internal tandem duplication mutations associated with human acute myeloid leukemias induce myeloproliferative disease in a murine bone marrow transplant model
Blood,
January 1, 2002;
99(1):
310 - 318.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
T. Dervieux, J. G. Blanco, E. Y. Krynetski, E. F. Vanin, M. F. Roussel, and M. V. Relling
Differing Contribution of Thiopurine Methyltransferase to Mercaptopurine versus Thioguanine Effects in Human Leukemic Cells
Cancer Res.,
August 1, 2001;
61(15):
5810 - 5816.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
G. Vassilopoulos, G. Trobridge, N. C. Josephson, and D. W. Russell
Gene transfer into murine hematopoietic stem cells with helper-free foamy virus vectors
Blood,
August 1, 2001;
98(3):
604 - 609.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. Frantsve, J. Schwaller, D. W. Sternberg, J. Kutok, and D. G. Gilliland
Socs-1 Inhibits TEL-JAK2-Mediated Transformation of Hematopoietic Cells through Inhibition of JAK2 Kinase Activity and Induction of Proteasome-Mediated Degradation
Mol. Cell. Biol.,
May 15, 2001;
21(10):
3547 - 3557.
[Abstract]
[Full Text]
|
|
|
|
|
|
|
A. C. Nathwani, A. Davidoff, H. Hanawa, J.-F. Zhou, E. F. Vanin, and A. W. Nienhuis
Factors influencing in vivo transduction by recombinant adeno-associated viral vectors expressing the human factor IX cDNA
Blood,
March 1, 2001;
97(5):
1258 - 1265.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
I. Hamaguchi, N.-B. Woods, I. Panagopoulos, E. Andersson, H. Mikkola, C. Fahlman, R. Zufferey, L. Carlsson, D. Trono, and S. Karlsson
Lentivirus Vector Gene Expression during ES Cell-Derived Hematopoietic Development In Vitro
J. Virol.,
November 15, 2000;
74(22):
10778 - 10784.
[Abstract]
[Full Text]
|
|
|
|
|
|
|
S. Ragg, M. Xu-Welliver, J. Bailey, M. D’Souza, R. Cooper, S. Chandra, R. Seshadri, A. E. Pegg, and D. A. Williams
Direct Reversal of DNA Damage by Mutant Methyltransferase Protein Protects Mice against Dose-intensified Chemotherapy and Leads to in Vivo Selection of Hematopoietic Stem Cells
Cancer Res.,
September 1, 2000;
60(18):
5187 - 5195.
[Abstract]
[Full Text]
|
|
|
|
|
|
|
P. G. Stevenson, S. Efstathiou, P. C. Doherty, and P. J. Lehner
Inhibition of MHC class I-restricted antigen presentation by gamma 2-herpesviruses
PNAS,
July 5, 2000;
(2000)
150240097.
[Abstract]
[Full Text]
|
|
|
|
|
|
|
R. C. Quackenbush, G. W. Reuther, J. P. Miller, K. D. Courtney, W. S. Pear, and A. M. Pendergast
Analysis of the biologic properties of p230 Bcr-Abl reveals unique and overlapping properties with the oncogenic p185 and p210 Bcr-Abl tyrosine kinases
Blood,
May 1, 2000;
95(9):
2913 - 2921.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
D. H. Patel, J. A. Allay, J. A. Belt, and B. P. Sorrentino
Retroviral transfer of the hENT2 nucleoside transporter cDNA confers broad-spectrum antifolate resistance in murine bone marrow cells
Blood,
April 1, 2000;
95(7):
2356 - 2363.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
S. Huang and S. J. Brandt
mSin3A Regulates Murine Erythroleukemia Cell Differentiation through Association with the TAL1 (or SCL) Transcription Factor
Mol. Cell. Biol.,
March 15, 2000;
20(6):
2248 - 2259.
[Abstract]
[Full Text]
|
|
|
|
|
|
|
M. Kieslinger, I. Woldman, R. Moriggl, J. Hofmann, J.-C. Marine, J. N. Ihle, H. Beug, and T. Decker
Antiapoptotic activity of Stat5 required during terminal stages of myeloid differentiation
Genes & Dev.,
January 15, 2000;
14(2):
232 - 244.
[Abstract]
[Full Text]
|
|
|
|
|
|
|
R. E. Donahue, R. P. Wersto, J. A. Allay, B. A. Agricola, M. E. Metzger, A. W. Nienhuis, D. A. Persons, and B. P. Sorrentino
High levels of lymphoid expression of enhanced green fluorescent protein in nonhuman primates transplanted with cytokine-mobilized peripheral blood CD34+ cells
Blood,
January 15, 2000;
95(2):
445 - 452.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
D. A. Williams, A. W. Nienhuis, R. G. Hawley, and F. O. Smith
Gene Therapy 2000
Hematology,
January 1, 2000;
2000(1):
376 - 393.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
S. Halene, L. Wang, R. M. Cooper, D. C. Bockstoce, P. B. Robbins, and D. B. Kohn
Improved Expression in Hematopoietic and Lymphoid Cells in Mice After Transplantation of Bone Marrow Transduced With a Modified Retroviral Vector
Blood,
November 15, 1999;
94(10):
3349 - 3357.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. Kume, M. Hashiyama, T. Suda, and K. Ozawa
Green Fluorescent Protein as a Selectable Marker of Retrovirally Transduced Hematopoietic Progenitors
Stem Cells,
July 1, 1999;
17(4):
226 - 232.
[Abstract]
[Full Text]
|
|
|
|
|
|
|
M. L. Holmes, J. D. Haley, L. Cerruti, W.-l. Zhou, H. Zogos, D. E. Smith, J. M. Cunningham, and S. M. Jane
Identification of Id2 as a Globin Regulatory Protein by Representational Difference Analysis of K562 Cells Induced To Express gamma -Globin with a Fungal Compound
Mol. Cell. Biol.,
June 1, 1999;
19(6):
4182 - 4190.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
C. E.J. Pritchard, M. Fornerod, L. H. Kasper, and J. M.A. van Deursen
RAE1 Is a Shuttling mRNA Export Factor That Binds to a GLEBS-like NUP98 Motif at the Nuclear Pore Complex through Multiple Domains
J. Cell Biol.,
April 19, 1999;
145(2):
237 - 254.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
D. A. Persons, J. A. Allay, E. R. Allay, R. A. Ashmun, D. Orlic, S. M. Jane, J. M. Cunningham, and A. W. Nienhuis
Enforced Expression of the GATA-2 Transcription Factor Blocks Normal Hematopoiesis
Blood,
January 15, 1999;
93(2):
488 - 499.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
S. Erlich, S. R.P. Miranda, J. W.M. Visser, A. Dagan, S. Gatt, and E. H. Schuchman
Fluorescence-Based Selection of Gene-Corrected Hematopoietic Stem and Progenitor Cells From Acid Sphingomyelinase-Deficient Mice: Implications for Niemann-Pick Disease Gene Therapy and the Development of Improved Stem Cell Gene Transfer Procedures
Blood,
January 1, 1999;
93(1):
80 - 86.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
P. G. Stevenson, S. Efstathiou, P. C. Doherty, and P. J. Lehner
Inhibition of MHC class I-restricted antigen presentation by gamma 2-herpesviruses
PNAS,
July 18, 2000;
97(15):
8455 - 8460.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. Priller, D. A. Persons, F. F. Klett, G. Kempermann, G. W. Kreutzberg, and U. Dirnagl
Neogenesis of cerebellar Purkinje neurons from gene-marked bone marrow cells in vivo
J. Cell Biol.,
November 26, 2001;
155(5):
733 - 738.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
